Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery

[1]  P. Siesjö,et al.  Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma , 2018, Endocrine.

[2]  S. Corsello,et al.  Current best practice in the management of patients after pituitary surgery , 2017, Therapeutic advances in endocrinology and metabolism.

[3]  J. Ramm-Pettersen,et al.  Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing’s disease , 2015, BMC Endocrine Disorders.

[4]  L. Calvi,et al.  MORNING SERUM CORTISOL LEVEL AFTER TRANSSPHENOIDAL SURGERY FOR PITUITARY ADENOMA PREDICTS HYPOTHALAMIC-PITUITARY-ADRENAL FUNCTION DESPITE INTRAOPERATIVE DEXAMETHASONE USE. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  Chiyuan Ma,et al.  Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis , 2015, PloS one.

[6]  D. Kelly,et al.  Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts. , 2013, World neurosurgery.

[7]  Jacqueline M. Regan,et al.  Selective Use of Peri-Operative Steroids in Pituitary Tumor Surgery: Escape from Dogma , 2013, Front. Endocrinol..

[8]  M. Burt,et al.  Perioperative management of the hypothalamic‐pituitary‐adrenal axis in patients with pituitary adenomas: an Australasian survey , 2012, Internal medicine journal.

[9]  M. Cusimano,et al.  Transphenoidal surgery without steroid replacement in patients with morning serum cortisol below 9 μg/dl (250 Nmol/l) , 2012, Acta Neurochirurgica.

[10]  Nicholas F. Marko,et al.  Immediate postoperative cortisol levels accurately predict postoperative hypothalamic–pituitary–adrenal axis function after transsphenoidal surgery for pituitary tumors , 2010, Pituitary.

[11]  E. Kilpatrick,et al.  National UK audit of the Short Synacthen® Test , 2010, Annals of clinical biochemistry.

[12]  Nicholas F. Marko,et al.  Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation. , 2009, Journal of neurosurgery.

[13]  N. Martin,et al.  Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors. , 2009, Clinical chemistry.

[14]  P. Marik,et al.  Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. , 2008, Archives of surgery.

[15]  D. D. de Lange,et al.  Perioperative glucocorticosteroid supplementation is not supported by evidence. , 2008, European journal of internal medicine.

[16]  J. Schramm,et al.  Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study , 2008, Acta Neurochirurgica.

[17]  A. Kaye,et al.  Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary , 2008, Clinical endocrinology.

[18]  P. Stewart,et al.  The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  J. Seckl,et al.  Assessing the HPA axis in patients with pituitary disease: a UK survey , 2006, Clinical endocrinology.

[20]  E. Laws,et al.  Perioperative Management of Patients Undergoing Transsphenoidal Pituitary Surgery , 2005, Anesthesia and analgesia.

[21]  W. Inder,et al.  Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management. , 2002, The Journal of clinical endocrinology and metabolism.

[22]  K. Meeran,et al.  Is a 0900-h serum cortisol useful prior to a short Synacthen test in outpatient assessment? , 2002, Annals of clinical biochemistry.

[23]  S. Jabbour.  Steroids and the surgical patient. , 2001, The Medical clinics of North America.

[24]  G. Besser,et al.  Corticosteroid treatment and surgery. 2. The management of steroid cover. , 1970, Anaesthesia.

[25]  G. Besser,et al.  Corticosteroid treatment and surgery , 1969 .

[26]  L. Lewis,et al.  Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone treatment. , 1953, Annals of internal medicine.

[27]  C. Fraser,et al.  Adrenal atrophy and irreversible shock associated with cortisone therapy. , 1952, Journal of the American Medical Association.